Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Milestone Pharmaceuticals Inc (NASDAQ: MIST)

 
MIST Technical Analysis
5
As on 9th Jun 2023 MIST STOCK Price closed @ 3.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.55 & Strong Sell for SHORT-TERM with Stoploss of 6.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MISTSTOCK Price

Open 4.00 Change Price %
High 4.06 1 Day -0.05 -1.25
Low 3.80 1 Week 0.01 0.25
Close 3.95 1 Month 0.30 8.22
Volume 64300 1 Year -3.18 -44.60
52 Week High 9.50 | 52 Week Low 3.14
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
MIST
Daily Charts		 MIST
Intraday Charts		 Whats New @
Bazaartrend		 MIST
Free Analysis
 
MIST Important Levels Intraday
RESISTANCE4.45
RESISTANCE4.29
RESISTANCE4.19
RESISTANCE4.09
SUPPORT3.81
SUPPORT3.71
SUPPORT3.61
SUPPORT3.45
 
MIST Forecast May 2024
Share
4th UP Forecast9.19
3rd UP Forecast7.51
2nd UP Forecast6.47
1st UP Forecast5.43
1st DOWN Forecast2.47
2nd DOWN Forecast1.43
3rd DOWN Forecast0.39
4th DOWN Forecast-1.29
 
MIST Weekly Forecast
4th UP Forecast6.32
3rd UP Forecast5.56
2nd UP Forecast5.09
1st UP Forecast4.62
1st DOWN Forecast3.28
2nd DOWN Forecast2.81
3rd DOWN Forecast2.34
4th DOWN Forecast1.58
 
MIST Forecast2024
4th UP Forecast16.96
3rd UP Forecast12.79
2nd UP Forecast10.21
1st UP Forecast7.63
1st DOWN Forecast0.27
2nd DOWN Forecast-2.31
3rd DOWN Forecast-4.89
4th DOWN Forecast-9.06
 
 
MIST Other Details
Segment EQ
Market Capital 167137600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MIST Address
MIST
 
MIST Latest News
 
Your Comments and Response on Milestone Pharmaceuticals Inc
 
MIST Business Profile
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as in the Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate, and other cardiovascular indications. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil in patients with paroxysmal supraventricular tachycardia and additional cardiovascular conditions in Greater China. The company was incorporated in 2003 and is headquartered in Montréal, Canada. Address: 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service